GO 289)(694522-87-7)
- Name: GO 289)
- Synonyms:GO 289);GO289 (GO-289;Phenol, 5-bromo-2-methoxy-4-[[[3-(methylthio)-5-phenyl-4H-1,2,4-triazol-4-yl]imino]methyl]-;(EZ)-GO289;5-Bromo-2-methoxy-4-(((3-(methylthio)-5-phenyl-4H-1,2,4-triazol-4-yl)imino)methyl)phenol;Inhibitor,cancer,(E/Z)GO289,circadian,(E/Z)-GO-289,cell,clock,rhythms,growth,(E/Z) GO289,phosphorylation,(E/Z)-GO289,Casein Kinase,inhibit;(E/Z） O289;(E/Z)-GO289, 10 mM in DMSO
- Molecular Formula:C17H15BrN4O2S
- Molecular Weight:419.3
- CAS Registry Number:694522-87-7
- EINECS:
- Melting Point:618.0±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 694487-04-2/Acetamide, N-[1-[1-[(4-methylphenyl)methyl]-1H-benzimidazol-2-yl]ethyl]-
- 694488-64-7/1-[(2-fluorophenyl)methyl]-2-(furan-2-yl)benzimidazole
- 694489-77-5/4H-1-Benzopyran-4-one, 2-[3-(β-D-glucopyranosyloxy)-4-methoxyphenyl]-5,7-dihydroxy-3-[(2-O-β-D-xylopyranosyl-β-D-glucopyranosyl)oxy]-
- 694491-84-4/O,O-dibutyl Te-phenyl phosphorotelluroate
- 694495-62-0/(3S,4S)-1-Benzyl-n,4-dimethylpiperidin-3-amine HCl
- 694497-84-2/N-{2-[(cyclohexylamino)carbonyl]phenyl}-4-biphenylcarboxamide
- 694497-90-0/3-ethyl-7-[(4-methoxyphenyl)methoxy]-4,8-dimethylchromen-2-one
- 694498-08-3/2-(methoxymethyl)-1-(1-phenylethyl)benzimidazole
- 694502-35-7/ethyl 7-(4-cyanophenyl)-5-phenyl-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate
- 694502-66-4/Carbonic acid, methyl 7,8,9,10-tetrahydro-6-oxo-6H-dibenzo[b,d]pyran-3-yl ester
- 694505-05-0/methyl 2-[4,8-dimethyl-7-(2-methylprop-2-enoxy)-2-oxochromen-3-yl]acetate
- 694505-13-0/8,9-diphenyl-2-(2-pyridinyl)furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine
- 694508-45-7/1-(2,5-dimethylphenyl)-4-(phenylsulfonyl)piperazine
- 694514-18-6/Benzenesulfonyl chloride, 3-methoxy-4-(trifluoromethyl)-
- 694514-97-1/4-[(4-azepan-1-ylphenyl)amino]-4-oxobutanoic acid
- 694515-09-8/N-(4-fluorophenyl)-3-[(4-methylphenyl)sulfonyl]propanamide
- 694515-19-0/1-(4-methoxyphenyl)-2-(naphthalen-2-ylsulfonyl)ethanone
- 694515-77-0/3-[7-[(3-methoxyphenyl)methoxy]-4,8-dimethyl-2-oxochromen-3-yl]propanoic acid
- 694517-02-7/Ethanone, 1-[4-(4-ethyl-1-piperazinyl)-3-fluorophenyl]-
- 694522-87-7/GO 289)
- 694533-15-8/N-(2-methoxyethyl)cyclopentanamine
- 69454-43-9/3-(pyrrolidine-1-carbonyl)-1,2-dihydroisoquinolin-1-one
- 69456-30-0/trans-Bis(triethylphosphine)(2,4,6-trimethylphenyl)nickel(II) bromide >=95%
- 6945-75-1/[2,2'-Binaphthalene]-1,1',6,6',7,7'-hexol, 3,3'-dimethyl-5,5'-bis(1-methylethyl)-8,8'-bis[[[4-nitro-3-(trifluoromethyl)phenyl]imino]methyl]-
- 69460-45-3/L-Phenylalanine, N-(2-methyl-1-oxobutyl)-
- 69460-98-6/Antibiotic 6016 sodium salt
- 69462-70-0/Aquivion(R) P87S-SO2F cylindrical pellets 2mm, PFSF eq. wt. (870 g/mole SO2F), contains CF3 polymer chain ends as stabilizer
- 69462-92-6/N-[2-(benzylsulfamoyl)ethyl]benzamide
- 69464-43-3/Ethanone, 1-(2,3-dihydro-8-methyl-1,4-benzodioxin-6-yl)-
- 69477-29-8/2,6-bis-(Diethanolamino)-4,8-dipiperidinopyrimido-(5,4-d)-pyrimidine, tosylat salt